Literature DB >> 15129954

To age or not to age.

Peter D Sozou1, Robert M Seymour.   

Abstract

According to the antagonistic pleiotropy theory of ageing, natural selection has favoured genes conferring short-term benefits to the organism at the cost of deterioration in later life. The 'disposable soma' theory expresses this as a life-history strategy in which somatic maintenance is below the level required to prevent ageing, thus enabling higher immediate fertility. It has been argued that a non-ageing strategy will always be bettered by a low but non-zero rate of ageing, because the costs of such ageing will be felt only in the distant future when they are of negligible importance. Here, we examine this argument critically. We find that a non-ageing strategy will be locally optimal if, in the presence of ageing, the onset of deterioration is sufficiently rapid or early. Conversely, ageing will be optimal if deterioration is sufficiently slow or late. As the temporal profile of ageing changes from one of steady deterioration to one involving a sudden loss of vitality after a period of little or no decline, the conditions for a non-ageing strategy to be locally optimal become progressively more stringent. But for all forms of profile considered, conditions can be found for which a strategy involving no ageing is locally optimal.

Entities:  

Mesh:

Year:  2004        PMID: 15129954      PMCID: PMC1691620          DOI: 10.1098/rspb.2003.2614

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  8 in total

1.  Senescence: rapid and costly ageing in wild male flies.

Authors:  Russell Bonduriansky; Chad E Brassil
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

2.  Augmented discounting: interaction between ageing and time-preference behaviour.

Authors:  Peter D Sozou; Robert M Seymour
Journal:  Proc Biol Sci       Date:  2003-05-22       Impact factor: 5.349

Review 3.  Evolution of senescence: late survival sacrificed for reproduction.

Authors:  T B Kirkwood; M R Rose
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1991-04-29       Impact factor: 6.237

4.  Antagonistic pleiotropy, mortality source interactions, and the evolutionary theory of senescence.

Authors:  Paul D Williams; Troy Day
Journal:  Evolution       Date:  2003-07       Impact factor: 3.694

5.  A network theory of ageing: the interactions of defective mitochondria, aberrant proteins, free radicals and scavengers in the ageing process.

Authors:  A Kowald; T B Kirkwood
Journal:  Mutat Res       Date:  1996-05       Impact factor: 2.433

Review 6.  Optimality, mutation and the evolution of ageing.

Authors:  L Partridge; N H Barton
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

7.  The moulding of senescence by natural selection.

Authors:  W D Hamilton
Journal:  J Theor Biol       Date:  1966-09       Impact factor: 2.691

Review 8.  Mechanisms of ageing: public or private?

Authors:  Linda Partridge; David Gems
Journal:  Nat Rev Genet       Date:  2002-03       Impact factor: 53.242

  8 in total
  5 in total

1.  We age because we grow.

Authors:  Hillard S Kaplan; Arthur J Robson
Journal:  Proc Biol Sci       Date:  2009-02-25       Impact factor: 5.530

Review 2.  Development of Facial Rejuvenation Procedures: Thirty Years of Clinical Experience with Face Lifts.

Authors:  Byung Jun Kim; Jun Ho Choi; Yoonho Lee
Journal:  Arch Plast Surg       Date:  2015-09-15

3.  Interaction mortality: senescence may have evolved because it increases lifespan.

Authors:  Maarten J Wensink; Tomasz F Wrycza; Annette Baudisch
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

4.  Beneficial cumulative effects of old parental age on offspring fitness.

Authors:  Laura M Travers; Hanne Carlsson; Martin I Lind; Alexei A Maklakov
Journal:  Proc Biol Sci       Date:  2021-10-13       Impact factor: 5.349

5.  Density dependence triggers runaway selection of reduced senescence.

Authors:  Robert M Seymour; C Patrick Doncaster
Journal:  PLoS Comput Biol       Date:  2007-11-14       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.